胃小间质瘤：诊断、治疗与预后评估的研究进展
摘要
道的任何部位，包括肠道、肠系膜、网膜和腹膜，但最好发于胃，约占所有 GIST的 50%以上。既往专家共识中把
直径小于 2cm的胃间质瘤（Gastic stromal tumor，GST）称之为胃小间质瘤，因其临床症状不典型，故其发病隐匿，
较难为检出。但随着内镜与影像诊断技术的不断提高以及大众自我健康管理意识的长足进步，胃小间质瘤的整体
检出率呈逐年增高趋势，虽然近年来有关胃小间质瘤研究及相关病例报道的文章屡见不鲜，可是目前针对胃小间
质瘤的治疗国内外暂未形成较为明确统一的指南。本文将以综述的形式针对胃小间质瘤的临床研究进展及热点问
题进行论述。
关键词
全文:
PDF参考
[1]沈琳，曹晖，秦叔逵，等.中国胃肠间质瘤诊
断治疗共识（2017年版）[J].肿瘤综合治疗电子杂志，
2018，4（01）：31-43.
[2]Aditya P ,Shriya H ,Prabhat N , et al.Gastrointestinal
Stromal Tumor: A Clinicopathological Study and
Management.[J].Cureus,2023,15(11):e49469-e49469.
[3]Takeshi N ,Hiromu S ,Tamotsu S .Molecular
characterization and pathogenesis of gastrointestinal
stromal tumor.[J].Translational gastroenterology and
hepatology,2018,3(1):2.
[4]Indio V ,Astolfi A ,Tarantino G , et al.Integrated
Molecular Characterization of Gastrointestinal Stromal
Tumors (GIST) Harboring the Rare D842V Mutation
in PDGFRA Gene[J].International Journal of Molecular
Sciences,2018,19(3):732-732.
[5]A W F ,Yotam D ,E S J , et al.Altered chromosomal
topology drives oncogenic programs in SDH-deficient GIST.
[J].Nature,2019,575(7781):229-233.
[6 ]Menge F , Jakob J ,Ka spe r B , et al.Clinical
Presentation of Gastrointestinal Stromal Tumors[J].Visceral
Medicine,2018,34(5):335-340.
[ 7 ]H u o l u n F ,W e i x i a n H , C h e n g b i n Z , et
al.Clinical Features of Extragastrointestinal Stromal Tumor
Compared with Gastrointestinal Stromal Tumor: A
Retrospective, Multicenter, Real-World Study.[J].Journal of
oncology,2021,20211460131-1460131.
[8]韦振轩，周永淳，张伟，等.胃肠间质瘤临床诊
断及治疗研究进展 [J].中外医疗，2022，41（07）：194-
198.DOI：10.16662/j.cnki.1674-0742.2022.07.194.
[9]叶颖江，沈琳，李健，等.小胃肠间质瘤诊疗中
国专家共识（2020年版）[J].临床肿瘤学杂志，2020，25
（04）：349-355.
[10]X.X.Jia，L.J.Wang，X.S.Chen， 等.胃 间 质 瘤
（1-2cm）的危险分层：CT和 EUS高危特征的视觉评估
与 CT影像组学对照分析 [J].国际医学放射学杂志，2023，
46（03）：370-371.DOI：10.19300/j.2023.e0410.
[11]曹晖，高志冬，何裕隆，等.胃肠间质瘤规范化
外科治疗中国专家共识（2018版）[J].中国实用外科杂志，
2018，38（09）：965-973.DOI：10.19538/j.cjps.issn1005-
2208.2018.09.01.
[12]赵凯越，张凯，王国鑫，等.内镜下全层切除术
后诊断为中危险度胃小间质瘤一例并文献回顾 [J].中华肿
瘤防治杂志，2021，28（06）：474-477.DOI：10.16073/
j.cnki.cjcpt.2021.06.11.
[13]Zhang Y, Mao XL, Zhou XB, Yang H, Zhu
LH, Chen G, Ye LP. Long-term outcomes of endoscopic
resection for small (≤ 4.0 cm) gastric gastrointestinal stromal
102
tumors originating from the muscularis propria layer. World J
Gastroenterol. 2018 Jul 21;24(27):3030-3037. doi: 10.3748/
wjg.v24.i27.3030IF: 4.3 Q1 . PMID: 30038470; PMCID:
PMC6054947.
[14]李子禹，李双喜，季加孚.胃肠间质瘤术前靶向
药物治疗与手术时机选择 [J].中国实用外科杂志，2018，
38（05）：494-497.DOI：10.19538/j.cjps.issn1005-
2208.2018.05.02.
[15]Heikki J .KIT and PDGFRA Variants and the
Survival of Patients with Gastrointestinal Stromal Tumor
Treated with Adjuvant Imatinib.[J].Cancers,2023,15(15).
[16]Aldo V D ,Gloria R ,Francesca G , et al.The
multifaceted landscape behind imatinib resistance in
gastrointestinal stromal tumors (GISTs): A lesson from
ripretinib.[J].Pharmacology & therapeutics,2023,248108475-
108475.
[17 ]17Yingying X ,Wenqing H ,Keyuan X , et
al.The current state of chemotherapy for the treatment of
gastrointestinal stromal tumors with different genotypes:a
narrative review[J].Journal of Bio-X Research,2021.
[18]18Haidong Z ,Tianxiang J ,Mingchun M , et
al.Radiotherapy in the Management of Gastrointestinal Stromal
Tumors: A Systematic Review[J].Cancers,2022,14(13):3169-
3169.
[19]Liu X, Chu KM. Molecular biomarkers for prognosis
of gastrointestinal stromal tumor. Clin Transl Oncol. 2019
Feb;21(2):145-151. doi: 10.1007/s12094-018-1914-4IF:
2.8 Q2 IF: 2.8 Q2 . Epub 2018 Jul 12. PMID: 30003531IF:
2.8 Q2 .
[20]Chunhui S ,Zhou C ,Zhijian L , et al.Gastric
gastrointestinal stromal tumors: therapeutic strategies and
long-term prognosis.[J].Scandinavian journal of gastroenterol
ogy,2023,59(2):1-7.
[21]Haoran Q ,Na Y ,Xiaotong H , et al.Corrigendum:
Molecular Portrait o f GIST Associated With
Clinicopathological Features: A Retrospective Study With
Molecular Analysis by a Custom 9-Gene Targeted NextGeneration Sequencing Panel[J].Frontiers in Genetics,2022,13
Refbacks
- 当前没有refback。
